BOFAS VTE Position Statement BOFAS VTE Position Statement Updated Statement June 2025 20 July 2025 Click here to access the newly updated BOFAS Position Statement for VTE Prophylaxis Read more
Registration Open for BOFAS 2025 (Nov) Registration Open for BOFAS 2025 (Nov) Click to Register Now! 25 June 2025 Read more
New Speciality Standards New Speciality Standards Management of End Stage Ankle Arthritis 05 April 2025 Click here to access the latest BOFAS-BOA Standards for management of End Stage Ankle Arthritis Read more
2Oct2025 BOFAS Principles Course - Dubai 02/10/2025 - 04/10/2025 Read more The aim is to give Overseas Trainee Orthopaedic Surgeons a solid grounding in the principles and the decision making in Foot & Ankle Surgery. There is an emphasis on clinical examination of cases, small group discussions and learning surgical approaches in the cadaver lab. This is the first course BOFAS is running in UAE and the aim is to expand the Foot and Ankle education and training in the Middle East and Gulf area. Venue - Le Meridien, Dubai, United Arab Emirates Documents to download ACv3BOFAS-Principles-Course-Programme-DXB(.pdf, 2.13 MB) - 523 download(s) Read more
20Oct2025 BOFAS Principles Course Taunton 20/10/2025 - 21/10/2025 Read more These courses are aimed at Higher Surgical Trainees / ST3 onwards and are designed to teach the core of Foot and Ankle surgery in an informal and interactive environment. The emphasis is on clinical examination cases, discussion groups and typical day-to-day clinic scenarios. Although not an exam preparation course, content is taught to the standard expected in the FRCS(Tr & Orth) exam; that of a day-one non-specialist orthopaedic consultant. Applications will open on 1st September 2023. Venue - Taunton (TBC) Documents to download BOFAS-Course-Programme--Taunton-2025(.docx, 31.88 KB) - 764 download(s) Read more
Togay Koç / 08 July 2022 / Categories: Abstracts, 2015, Poster Randomised controlled trial comparing corticosteroid injection for Morton's neuroma with or without ultrasound guidance - results at 12 months post-intervention D. Mahadevan, R. Bhatt, M. Attwal, M. Bhatia Introduction: The objective of this double-blind RCT was to assess whether ultrasound guidance improved the efficacy of corticosteroid injections for Morton's neuroma. Methods: 50 feet (40 patients) were recruited for this study. 5 cases declined further participation and were excluded. The mean age was 57.8 years with a female preponderance (33F:12M) and patients were followed-up for 12 months. Cases were randomised to receive an ultrasound guided (Group A) or non-ultrasound guided (Group B) injection of 40mg triamcinolone acetonide and 2ml 1% lignocaine. Results: The mean VAS pain score improved significantly in both groups (Group A - from 64 to 29mm; Group B - from 69 to 37mm) with no statistical difference between them at all time-points. The failure rate within 12 months of treatment was 48% and 55% in Groups A and B respectively (p=0.458). The improvement in MOxFQ-Index and patient satisfaction favoured Group A in the short-term (3 months) that almost reached statistical significance (p=0.059 and 0.066 respectively). However, this difference was not observed beyond 3 months. Conclusion: This study had shown that US guidance did not demonstrably improve the efficacy of corticosteroid injections in patients with MN. Print 561 Tags: Nerves